ENPP1 promotes an immunosuppressive tumor microenvironment by the imbalance of ATP/adenosine and impairs the STING (stimulator of interferon genes) pathway immune response by the hydrolysis of the effector cGMP–AMP [44]. The gene discussed is ENPP1; the disease is neoplasm.